Enhanced fear expression in a psychphathological mouse model of trait anxiety: pharmacological interventions by Hauschild, Markus et al.
MEETING ABSTRACT Open Access
Enhanced fear expression in a psychphathological
mouse model of trait anxiety: pharmacological
interventions
Markus Hauschild
1, Simone B Sartori
1, Mirjam Bunck
2,3, Stefano Gaburro
1, Rainer Landgraf
2, Nicolas Singewald
1*
From 16th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
Vienna, Austria. 25-27 November 2010
Background
The propensity to develop an anxiety disorder is
thought to be determined by genetic and environmental
factors. Here we investigated the relationship between
an extreme genetic predisposition to trait anxiety and
experience-based learned fear in a psychopathological
mouse model.
Methods
Male CD-1 mice selectively bred for either high (HAB)
or normal (NAB) anxiety-related behaviour on the ele-
vated plus maze were subjected to classical fear
conditioning.
Results
Both mouse lines learned to fear an initially neutral
stimulus (CS) being indicated by increasing freezing
levels. 24 h later, HAB mice displayed more pro-
nounced freezing responses to both the context and
cue CS compared with NAB mice, suggesting that trait
anxiety determines stronger fear memory and/or a
weaker ability to inhibit fear responses in the HAB
line. Interestingly, already 1 h and 6 h after fear condi-
tioning, freezing levels were high in HAB mice but not
in NAB mice. The enhanced fear response of HAB
mice was attenuated by treatment with either the
a2,3,5-subunit-selective benzodiazepine partial agonist
L-838,417, corticosterone or the selective neurokinin-1
receptor antagonist L-822,429.
Conclusions
Overall, the HAB mouse line may represent an interesting
model (i) for identifying biological factors underlying mis-
guided conditioned fear responses and (ii) for studying
novel pharmacotherapies for patients with anxiety disor-
ders, including post-traumatic stress disorder and phobias.
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